Related Experiment Video
Updated: Dec 11, 2025
12:09
Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
43.3K
COVID-19 Vaccine: A comprehensive status report
Simran Preet Kaur1, Vandana Gupta1
1Department of Microbiology, Ram Lal Anand College, University of Delhi, Benito Juarez Road, New Delhi 110021, India.
Virus Research
|August 18, 2020
Summary
Developing an effective COVID-19 vaccine requires careful validation of efficacy and safety, especially for high-risk groups. Various vaccine platforms are under evaluation to control SARS-CoV-2, the virus causing COVID-19.
Area of Science:
- * Virology and Immunology
- * Vaccinology
- * Epidemiology
Background:
- * The COVID-19 pandemic, caused by SARS-CoV-2, necessitates urgent development of vaccines and therapeutics.
- * Lessons from SARS-CoV and MERS inform SARS-CoV-2 vaccine strategies due to genetic similarities and shared host cell receptors (hACE2).
- * Early vaccine development efforts are underway globally, but an effective vaccine is not expected before late 2020.
Purpose of the Study:
- * To review the global efforts and strategies for developing an effective vaccine against SARS-CoV-2.
- * To provide an overview of various vaccine development platforms and their associated benefits and challenges.
- * To highlight the importance of rigorous validation for vaccine efficacy and safety, considering vulnerable populations.
Main Methods:
- * Review of published scientific literature and ongoing research on COVID-19 vaccines.
- * Analysis of different vaccine platforms including virus vectored, protein subunit, genetic vaccines, and monoclonal antibodies.
- * Consideration of factors influencing vaccine development timelines and validation requirements.
Main Results:
- * Multiple vaccine platforms are being evaluated for SARS-CoV-2, each with distinct advantages and disadvantages.
- * Successful vaccine development requires cautious validation of efficacy and safety, particularly for high-risk populations (elderly, healthcare workers, essential industry workers).
- * The need for rapid evaluation of vaccine approaches to elicit protective immunity and ensure safety, avoiding immune potentiation.
Conclusions:
- * The development of a safe and effective COVID-19 vaccine is a complex and lengthy process requiring international collaboration.
- * A range of vaccine technologies are being explored, and their suitability for SARS-CoV-2 needs thorough assessment.
- * Prioritizing safety and efficacy, especially in vulnerable populations, is crucial for controlling the devastating impact of the COVID-19 pandemic.
More Related Videos
Related Concept Videos
01:51Vaccinations
50.6K
Overview
50.6K
01:19Pharmacovigilance
1.5K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.5K
01:26Principles of Disease Surveillance
377
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
377
01:30Cancer Vaccines
860
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
860
01:13Bioequivalence studies: Biowaivers
118
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
118
01:11Clinical Trials: Overview
4.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K